Timing of treatment initiation in Parkinson's disease: a need for reappraisal?
Ann Neurol
.
2006 Mar;59(3):559-62.
doi: 10.1002/ana.20789.
Authors
Anthony H V Schapira
1
,
Jose Obeso
Affiliation
1
University Department of Clinical Neurosciences, Royal Free and University College Medical School, University College London, UK. a.schapira@medsch.ucl.ac.uk
PMID:
16489611
DOI:
10.1002/ana.20789
No abstract available
Publication types
Review
MeSH terms
Antiparkinson Agents / therapeutic use*
Health Services Needs and Demand*
Humans
Parkinson Disease / drug therapy*
Time Factors
Substances
Antiparkinson Agents